Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273 Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • The BNT162b2 and mRNA-1273 mRNA SARS-CoV-2 vaccines have demonstrated high efficacy for preventing short-term COVID-19. However, comparative long-term effectiveness is unclear, especially pertaining to the Delta variant.

authors

  • Grunau, Brian
  • Golding, Liam
  • Prusinkiewicz, Martin A
  • Asamoah-Boaheng, Michael
  • Armour, Richard
  • Marquez, Ana Citlali
  • Jassem, Agatha N
  • Barakauskas, Vilte
  • O’Brien, Sheila F
  • Drews, Steven J
  • Haig, Scott
  • Lavoie, Pascal M
  • Goldfarb, David

publication date

  • April 27, 2022